Related Experiment Video

Updated: Jul 10, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Use of intrapleural bortezomib in myelomatous pleural effusion

Emilio Iannitto, Viviana Minardi, Claudio Tripodo

    British Journal of Haematology
    |November 6, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
    07:54

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

    Published on: December 21, 2019

    Related Experiment Videos

    Last Updated: Jul 10, 2026

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
    07:54

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

    Published on: December 21, 2019

    Related Concept Videos

    Pleural Effusion I: Introduction01:25

    Pleural Effusion I: Introduction

    Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
    There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
    Pleural Effusion II: Symptoms and Management01:28

    Pleural Effusion II: Symptoms and Management

    Pleural Effusion Overview
    A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
    Clinical Manifestations:

    Articles linked to this work by shared authors, journal, and citation graph.

    Primary mediastinal B-cell lymphoma: a nationwide real-life retrospective study of first-line treatment approaches in Italy.

    Haematologica·2026

    Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies.

    Haematologica·2026

    PatternExtract: A Facile, Scalable Pipeline for Point Pattern Generation from Spatial Imaging Data.

    Computational and structural biotechnology journal·2026

    Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche.

    Leukemia·2026

    The telomeric DNA damage response as a therapeutic target in idiopathic pulmonary fibrosis.

    EMBO molecular medicine·2026

    Therapeutic inhibition of telomeric DNA damage response rescues hematopoietic dysfunction driven by telomere shortening and aging.

    Nature aging·2026

    Clinical outcome and infectious complications in genetic and suspected genetic neutropenia: A report from the Canadian Inherited Marrow Failure Registry.

    British journal of haematology·2026

    SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent.

    British journal of haematology·2026

    CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver.

    British journal of haematology·2026

    RESOLVE to do better.

    British journal of haematology·2026

    Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.

    British journal of haematology·2026

    Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests.

    British journal of haematology·2026

    Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

    Journal of visualized experiments : JoVE·2026

    Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

    Regenerative therapy·2026

    Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

    Regenerative therapy·2026

    Beyond immune suppression: regenerative programs in regulatory T cells.

    Cell insight·2026

    Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

    BMJ neurology open·2026

    DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

    Antibody therapeutics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us